News

Anil Singhvi stock recommendation: After a mixed session on Friday with markets pausing the six-day winning streak, fresh momentum is building in some key sectors as traders gear up for the week ahead. The pharmaceutical and IT sectors are catching attention, supported by positive signals and encouraging brokerage updates.

Zee Business Managing Editor Anil Singhvi has flagged Divi’s Laboratories and Infosys futures as his top picks this morning. He points to strong fundamentals and solid technical patterns driving optimism in both pharma and IT.

Singhvi recommends buying Divi’s Laboratories futures with a stop loss at Rs 6065 and targets at Rs 6220 and Rs 6280. This comes on the back of a recent upgrade from global brokerage Jefferies, which raised Divi’s rating from ‘Hold’ to ‘Buy’ and bumped up its target price to Rs 7,150 from Rs 6,750. That suggests more than 16 per cent upside from Friday’s close of Rs 6154. Jefferies highlighted Divi’s custom synthesis business and new product launches as key drivers expected to keep growth strong.

On the IT side, Singhvi is positive on Infosys futures, recommending a buy with a stop loss at Rs 1467 and targets of Rs 1509 and Rs 1524. After some recent consolidation, IT stocks are showing signs of bouncing back, thanks to improving global demand and higher client spending. 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

Senior Sub-editor at Zee Business English

shweta.shukla@India.com

Shweta Birendra Shukla is a journalist covering the stock market and corporate affairs, with prior stints at Business ...By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.